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Recently, the plasmid-mediated colistin resistance 
gene mcr-1 was found in Enterobacteriaceae from 
humans, pigs and retail meat in China. Several reports 
have documented global presence of the gene in 
Enterobacteriaceae from humans, food animals and 
food since. We screened several well-characterised 
strain collections of Enterobacteriaceae, obtained from 
retail chicken meat and hospitalised patients in the 
Netherlands between 2009 and 2015, for presence of 
colistin resistance and the mcr-1 gene. A total of 2,471 
Enterobacteriaceae isolates, from surveys in retail 
chicken meat (196 isolates), prevalence surveys in hos-
pitalised patients (1,247 isolates), clinical cultures (813 
isolates) and outbreaks in healthcare settings (215 iso-
lates), were analysed. The mcr-1 gene was identified in 
three (1.5%) of 196 extended-spectrum beta-lactamase 
(ESBL)-producing Escherichia coli isolates from retail 
chicken meat samples in 2009 and 2014. Two isolates 
were obtained from the same batch of meat samples, 
most likely representing contamination from a com-
mon source. No mcr-1-positive isolates were identified 
among 2,275 human isolates tested. All mcr-1-positive 
isolates were colistin-resistant (minimum inhibitory 
concentration (MIC) > 2 mg/L). Our findings indicate 
that mcr-1-based colistin-resistance currently poses no 
threat to healthcare in the Netherlands. They indicate 
however that continued monitoring of colistin resist-
ance and its underlying mechanisms in humans, live-
stock and food is needed.
Introduction
The worldwide emergence of extended-spectrum beta-
lactamases (ESBL) and carbapenemases has limited 
the available treatment options for infections with 
Gram-negative bacteria [1]. Colistin is considered to be 
an antibiotic of last resort for the treatment of infec-
tions with carbapenem-resistant bacteria, and its use 
in humans is increasing [1].
In November 2015, the presence of a plasmid-mediated 
colistin-resistance gene, mcr-1, in Enterobacteriaceae 
from food animals, food and patients in China was 
reported [2]. The mcr-1 gene was detected in 21% of 
Escherichia coli isolates cultured from pigs at slaugh-
ter and in 15% of E. coli isolates cultured from retail 
meat between 2011 and 2014. In addition, the mcr-1 
gene was present in 1.4% of E. coli isolates and 0.7% 
of Klebsiella pneumoniae isolates from clinical cultures 
from patients in two Chinese hospitals in 2014. Directly 
following this publication, the mcr-1 gene was reported 
to be present in 0.2% of ESBL- and AmpC-producing 
E. coli isolates from human bloodstream infections, 
and in 2% of E. coli isolates cultured from imported 
chicken meat in Denmark since 2012 [3].Hereafter, 
several reports have documented the global presence 
of the mcr-1 gene in Enterobacteriaceae cultured from 
humans, food animals and food [4-13].
Traditionally, colistin resistance was thought to be 
mediated by chromosomal mutations only, and to 
spread exclusively via clonal transmission of resist-
ant isolates [14]. The emergence of plasmid-mediated 
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Table 1
Enterobacteriaceae isolates from retail chicken meat, rectal samples, clinical cultures and outbreaks by year of culture, type 
of isolate, and colistin-resistance, analysed by whole genome sequencing for the presence of the mcr-1 gene, the Netherlands, 
2009–2015 (n = 2,471)










Retail chicken meat (n = 196) 
Prevalence survey (n = 74) 2009
ESBL-producing Escherichia coli 68 NAa 1
ESBL-producing Klebsiella pneumoniae 6 NA 0
Prevalence survey (n = 122) 2014
ESBL-producing E. coli 119 2 2
ESBL-producing K. pneumoniae 3 0 0
Hospitalised patients, rectal samples (n = 1,247) 
Prevalence survey, 4 hospitals 
(n = 50) 2009
ESBL-producing E. coli 39 NA 0
ESBL-producing K. pneumoniae 11 NA 0
Prevalence surveys, 1 hospital 
(n = 63) 2013–2014
ESBL-producing E. coli 54 0 0
ESBL-producing K. pneumoniae 8 0 0
ESBL-producing K. oxytoca 1 0 0
Prevalence surveys, 14 hospitals 
(n = 1,134) 2011–2014
ESBL-producing E. coli 821 2 0
ESBL-producing K. pneumoniae 172 3 0
ESBL-producing K. oxytoca 13 0 0
ESBLproducing Enterobacter cloacae 77 2 0
ESBL-producing Citrobacter spp. 38 1 0
ESBL-producing Morganella morganii 6 6b 0
Other ESBLproducing Enterobacteriaceae 7 0 0
Hospitalised patients, clinical cultures (n = 813) 
Blood cultures, 4 hospitals (n = 25)            2009           
ESBL-producing E. coli 16 NA 0
ESBL-producing K. pneumoniae 7 NA 0
ESBL-producing K. oxytoca 2 NA 0
Blood cultures, 4 hospitals (n = 77) 2013–2014
ESBL-producing E. coli 67c 0 0
ESBL-producing K. pneumoniae 8c 0 0
ESBL-producing K. oxytoca 2 0 0
Clinical cultures, 14 hospitals 
(n = 711) 2011–2014
ESBL-producing E. coli 546 4 0
ESBL-producing K. pneumoniae 101 2 0
ESBL-producing K. oxytoca 5 0 0
ESBL-producing E. cloacae 46 3 0
ESBL-producing Citrobacter spp. 4 0 0
ESBL-producing M. morganii 3 3b 0
ESBL-producing Proteus mirabilis 2 2b 0
ESBL-producing P. vulgaris group 1 1b 0
Other ESBL-producing Enterobacteriaceae 3 0 0
Outbreaks in healthcare settings (n = 215) 
Several wards, including 
rehabilitation centre (n = 29)d 2012–2015 CTX-M-15 producing K. pneumoniae 29 0 0
Surgical ward (n = 14) 2014 E. cloacae 14 0 0
Intensive care unit (n = 86) 2009–2014 Colistin-resistant E. cloacae 86 86 0
Nursing home (n = 10) 2012 Colistin-resistant KPC-producing K. pneumoniae 10 10 0
ERCP related procedures (n = 50) 2014–2015 Colistin-resistant K. pneumoniae 50 43 0
Neonatal intensive care unit 
(n = 26)d 2014–2015 Colistin-resistant Serratia marcescens 26 26
b 0
ERCP: endoscopic-retrograde cholangio-pancreaticography; ESBL: extended-spectrum beta-lactamase; KPC: Klebsiella pneumoniae carbapenemase; NA: not 
available.
a The mcr-1-positive isolate was tested colistin-resistant with Etest.
b Intrinsic resistance.
c Two E. coli isolates and one K. pneumoniae isolate were not available for whole genome sequencing.
d Outbreak and subsequent surveillance.
Colistin resistance was defined as a colistin minimum inhibitory concentration (MIC) > 2 mg/L, according to the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) clinical breakpoints [26].
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colistin resistance enables the much more efficient 
horizontal transfer of colistin resistance genes to other 
bacteria, making mcr-1 a potential threat to public 
health. The aim of this study was to screen several well-
documented strain collections of Enterobacteriaceae, 
obtained from retail chicken meat and hospitalised 
patients in the Netherlands since 2009, for the pres-
ence of colistin resistance and the mcr-1 gene.
Methods
Strain collections
A total number of 2,471 Enterobacteriaceae isolates 
were analysed for the presence of colistin resistance 
and the mcr-1 gene. Isolates originated from prevalence 
surveys in retail chicken meat (196 isolates), preva-
lence surveys in hospitalised patients (1,247 isolates), 
clinical cultures (813 isolates) and several outbreaks in 
healthcare settings (215 isolates), all collected in the 
Netherlands between 2009 and 2015.
Retail chicken meat
Two ESBL-producing Enterobacteriaceae (ESBL-E) prev-
alence surveys in Dutch retail chicken meat were per-
formed in 2009 and in 2014 [15,16]. A total number of 
196 ESBL-E isolates were obtained, 74 isolates from 71 
ESBL-E-positive meat samples in 2009 (89 samples cul-
tured), and 122 isolates from 86 ESBL-E-positive meat 
samples in 2014 (101 meat samples cultured).
Hospitalised patients, rectal samples
The retail chicken meat surveys in 2009 and 2014 were 
accompanied by hospital-wide prevalence surveys in 
patients who were admitted to four hospitals in the 
region where the chicken meat was bought [15,16]. In 
2009, ESBL-E rectal carriage was detected in 45 (5.1%) 
of 876 patients, who carried 50 ESBL-E isolates. Two 
repeated prevalence surveys in one of the four hos-
pitals in 2013 and 2014, yielded 63 ESBL-E isolates 
obtained from 63 (5.9%) ESBL-E carriers among 1,065 
patients cultured [17].
A multi-centre cluster-randomised study comparing 
contact isolation strategies for known ESBL-E carri-
ers was performed in 14 Dutch hospitals between 
2011 and 2014 (SoM study) [18]. All consecutive adult 
patients with a routine clinical culture with ESBL-E 
were placed on contact precautions and enrolled in the 
study (= index patient). Ward-based ESBL-E prevalence 
surveys were performed one week after enrolment of 
the index patient. Perianal swabs were obtained from 
10,691 patients and identified 992 (9.3%) ESBL-E car-
riers, from whom 1,134 ESBL-E isolates were cultured.
Hospitalised patients, clinical cultures
In 2009, 2013 and 2014, all consecutive ESBL-E isolates 
from blood cultures were prospectively collected in the 
four hospitals that participated in the ESBL-E rectal 
carriage prevalence surveys [15,16]. A total number of 
102 ESBL-isolates from blood cultures were obtained, 
25 isolates from 23 patients with an ESBL-E-positive 
blood culture in 2009, and 77 isolates from 76 patients 
in 2013 and 2014. Three isolates that were collected in 
2014 were not available for whole genome sequencing.
In the SoM study, a total number of 711 clinical ESBL-E 
isolates were obtained from 654 ESBL-E-positive 
patients.
Outbreaks in healthcare settings
Since 2009, several outbreaks with antimicrobial-
resistant bacteria in Dutch hospitals and nursing homes 
have been documented. Six outbreaks, comprising 215 
isolates, for which whole genome sequence data were 
available, were included in this analysis: (i) an out-
break of CTX-M-15-producing K. pneumoniae in several 
wards of a hospital and an associated rehabilitation 
centre in 2012–2015 (29 isolates) [19]; (ii) an outbreak 
of Enterobacter cloacae in a surgical ward in 2014 (14 
isolates); (iii) an outbreak of colistin-resistant E. cloa-
cae in an intensive care unit between 2009 and 2014 
(86 isolates); (iv) an outbreak of colistin-resistant KPC-
producing K. pneumoniae in a nursing home in 2012 
(10 isolates) [20]; (v) an outbreak of colistin-resistant 
K. pneumoniae in patients after endoscopic retrograde 
cholangio-pancreaticography (ERCP) procedures in 
Table 2
Characteristics of the mcr-1-positive Escherichia coli isolates from retail chicken meat, the Netherlands, 2009–2015





2009 A ST2079 O8:H19
aadA1, aadA2, aadA3, aph(3’)-la, 
aph(3”)-Ib, aph(3’)-lc, aph(6)-Id, 
blaCTX-M-1, blaTEM-1B, tet(A), mcr-1, 
lnu(F), cmlA1, catA1, sul2, sul3, 
dfrA5
FIB, FII, HI2, 




2014 B ST117 O159:H4 aadA1, blaSHV-12, mcr-1, sul1, sul3 FIB, FII
14M009387a Chicken meat
29 January 
2014 B ST117 O159:H4 aadA1, blaSHV-12, mcr-1, sul1, sul3 FIB, FII
MLST: multilocus sequence typing.
a Isolate 14M009386 and 14M009387 were cultured from different meat samples with the same lot number.
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2014–2015 (50 isolates); and (vi) an outbreak of (intrin-
sic) colistin-resistant Serratia marcescens in a neonatal 
intensive care unit in 2014–2015 (26 isolates).
Whole genome sequencing and analysis of 
sequence data
Whole genome sequencing (WGS) was performed, 
on either a MiSeq, HiSeq 2500 or NextSeq sequencer 
(Illumina). De novo assembly was performed using CLC 
genomics Workbench 7.0.4 (Qiagen) or the open source 
SPAdes 3.5.0 software (http://bioinf.spbau.ru/spades) 
[21]. Sequence data were screened for the presence of 
the mrc-1 gene by running the assembled sequences 
against a task template containing the mcr-1 gene 
sequence in Ridom SeqSphere + version 3.0.1 (Ridom, 
Germany) or by uploading the assembled sequences 
to the open access bioinformatic webtool ResFinder 
(updated version 2.1, including the mcr-1 sequence) 
of the Center for Genomic Epidemiology (http://www.
genomicepidemiology.org/) [22]. For isolates from 
two outbreaks (colistin-resistant E. cloacae and ERCP-
related colistin-resistant K. pneumonia), the thresholds 
for sequence identity and coverage length were set to 
98% and 60%, respectively, while for all other isolates 
both thresholds were set to 80%. The sequence data 
of the mcr-1-positive isolates were further analysed by 
using a genotyping plugin that allowed serotyping of 
the isolates and detection of acquired antibiotic resist-
ance genes and plasmids with a 80% threshold for both 
sequence identity and coverage length (BioNumerics 
v7.6 beta software, Applied Maths). Reference data 
for acquired antimicrobial resistance genes and plas-
mid replicons were retrieved from the ResFinder and 
PlasmidFinder databases (version 9 November 2015) 
of the Center for Genomic Epidemiology (http://www.
genomicepidemiology.org/) [22,23]. Whole genome 
multilocus sequence typing (wgMLST) analysis was 
performed using a pan-genome MLST scheme compris-
ing 9,347 genes, based on 19 well-annotated reference 
genomes of E. coli and Shigella spp. (BioNumerics v7.6 
beta, Applied Maths). Additionally, single nucleotide 
polymorphism (SNP) calling was performed by map-
ping the paired-end reads of isolate 14M009387 and 
isolate 213 to the de novo assembled genome of iso-
late 14M009386, using Bowtie 2.5.5 [24] and SAMtools 
[25]. Resulting Binary Alignment Maps (BAM) files were 
Table 3




MIC (mg/L) S/I/R MIC (mg/L) S/I/R MIC (mg/L) S/I/Ra
Polymyxins 
Colistin 3b R ≥ 16 R ≥ 16 R
Penicillins 
Ampicillin ≥ 32 R ≥ 32 R ≥ 32 R
Amoxicillin/clavulanic acid 8 S ≤ 2 S 4 S
Piperacillin/tazobactam ≤ 4 S ≤ 4 S ≤ 4 S
Cephalosporins 
Cefuroxime ≥ 64 R 16 R 16 R
Cefotaxime 8 R 4 R 4 R
Ceftazidime ≤ 1 S 16 R 16 R
Cefepime 2 I ≤ 1 S ≤ 1 S
Cefoxitin ≤ 4 Sc ≤ 4 Sc ≤ 4 Sc
Carbapenems 
Meropenem ≤ 0.25 S ≤ 0.25 S ≤ 0.25 S
Imipenem ≤ 0.25 S ≤ 0.25 S ≤ 0.25 S
Aminoglycosides 
Gentamicin ≤ 1.0 S ≤ 1 S ≤ 1 S
Tobramycin ≤ 1.0 S ≤ 1 S ≤ 1 S
Fluoroquinolones 
Ciprofloxacin 0.5 S ≤ 0.25 S ≤ 0.25 S
Norfloxacin 2 R ≤ 0.5 S ≤ 0.5 S
Folate pathway inhibitors 
Trimethoprim/sulfamethoxazol ≥ 16/304 R ≤ 1/19 S ≤ 1/19 S
I: intermediate; MIC: minimum inhibitory concentration; R: resistant; S: susceptible.
a According to the European Committee on Antimicrobial Susceptibility (EUCAST) clinical breakpoints [26].
b Etest: MIC = 3 mg/L; Vitek2: MIC = 2 mg/L.
c No clinical breakpoint available; S refers to the screening breakpoint for AmpC Enterobacteriaceae.
5www.eurosurveillance.org
used to perform whole genome SNP (wgSNP) analysis 
(BioNumerics v7.6 beta, Applied Maths).
Antimicrobial susceptibility testing
Isolates for which antimicrobial susceptibility data 
were available were screened for the presence of colis-
tin resistance. Susceptibility testing of the three mcr-
1-positive E. coli isolates was performed using Vitek2 
(bioMérieux, France) and Etest (bioMérieux, France). 
The breakpoint tables of the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) were 
used for the interpretation of minimum inhibitory con-
centrations (MICs) [26]. Isolates with a colistin MIC > 2 
mg/L were considered colistin-resistant.
Results
An overview of the 2,471 Enterobacteriaceae isolates 
from retail chicken meat, rectal samples, clinical cul-
tures and outbreaks is presented in Table 1. Colistin 
resistance was found in two (1.6%) of 122 chicken 
meat-derived ESBL-E isolates, in 14 (1.1%) of 1,247 iso-
lates from ESBL-E rectal carriers, and in 15 (1.8%) of 
813 ESBL-E isolates from clinical cultures. The mcr-1 
gene was detected in three (1.5%) of 196 chicken meat-
derived ESBL-producing E. coli isolates, one cultured in 
2009 and two in 2014. For all three isolates, the mcr-1 
sequence showed 100% similarity to the gene reported 
in China [2]. None of the 2,275 human isolates har-
boured the mcr-1 gene.
Table 2 shows the general and molecular charac-
teristics of the three mcr-1-positive E. coli isolates. 
The isolate that was cultured in 2009 had sequence 
type ST2079, was CTX-M-1-positive and harboured 17 
acquired resistance genes. Both isolates from 2014 had 
sequence type ST117, were SHV-12-positive and har-
boured five acquired resistance genes. Although these 
two isolates were cultured from different meat samples 
of non-Dutch origin, the meat samples had the same 
lot number and were bought in the same supermarket 
on the same day. Plasmid replicons were identified in 
all three isolates, eight in the isolate from 2009 and 
two in both isolates from 2014. However, none of the 
plasmid replicons could be linked to the mcr-1 gene.
Antimicrobial susceptibilities for the three mcr-1-pos-
itive E. coli isolates are shown in Table 3. All three 
isolates were colistin-resistant (MIC > 2 mg/L). The iso-
late from 2009 tested colistin-susceptible by Vitek2 
(MIC = 2 mg/L), but resistant by Etest (MIC = 3 mg/L). 
wgMLST analysis showed that the two isolates from 
2014 differed by only three (0.07%) of 4,243 shared 
loci, whereas the isolate from 2009 differed by 3,606 
(95.1%) of 3,791 shared loci (Table 4). The two iso-
lates from 2014 differed by only eight SNPs in wgSNP 
analysis.
Discussion
In our study, covering the period 2009 to 2015, we 
detected the recently described plasmid-mediated 
colistin resistance gene, mcr-1, in three ESBL-producing 
E. coli isolates from retail chicken meat samples 
obtained from Dutch supermarkets in 2009 and 2014. 
All three mcr-1-positive isolates were colistin-resistant, 
and two of them were genetically closely related. No 
mcr-1-positive isolates were detected in a large col-
lection of Enterobacteriaceae isolates of human origin 
that were collected during the same time period and 
included isolates of four outbreaks with colistin-resist-
ant Enterobacteriaceae.
In addition to the recent reports on the global occur-
rence of the mcr-1 gene in Enterobacteriaceae cultured 
from humans, food animals and food [2-13], our find-
ings confirm the presence of the mcr-1 gene in the 
European setting already since 2009.
The observed 1.5% prevalence of mcr-1-positive iso-
lates is comparable with the reported 2% (5/255) prev-
alence in imported chicken meat in Denmark, and is 
lower than the 15% (78/523) prevalence in retail meat 
in China [2,3]. This lower prevalence may be related to 
the relatively low rates of polymyxin use in livestock 
in Europe. In 2014, polymyxins constituted only 0.4% 
(0.34 defined daily dose animal (DDDA)/animal year) of 
all antibiotics used in broilers in the Netherlands, with 
a decreasing trend over the last few years [27].
It is noteworthy that the observed 1.5% prevalence of 
mcr-1-positive isolates in ESBL-E isolates from retail 
chicken meat in this study is similar to the 1.5% phe-
notypic colistin resistance that was found in E. coli iso-
lates cultured from Dutch retail chicken meat in 2014 
[27]. Unfortunately, no data are currently available on 
the resistance mechanisms involved in this phenotypic 
colistin resistance.
The genetic identity between the two mcr-1-positive 
isolates that were obtained from the same batch of 
meat samples most likely represents batch contamina-
tion from a common source.
The mcr-1-positive isolates in this study belong to differ-
ent sequence types as compared with those that were 
found to be related to the mcr-1 gene in the Chinese 
and Danish study [2,3]. E. coli ST2097 is uncommon in 
Table 4
Whole genome multilocus sequence typing analysis and 
whole genome single nucleotide polymorphism analysis 




Loci shared Different alleles within shared loci
SNP 
positions
n n % n
14M009387 4,243 3 0.07% 8
213 3,791 3,606 95.1% 100,215
MLST: multilocus sequence typing; SNP: single nucleotide 
polymorphism; wg: whole genome.
a Isolate 14M0009386 was used as reference.
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humans, but has been reported once before in a study 
on ESBL-producing bacteria in flies from broiler farms 
in the Netherlands [28]. E. coli ST117, on the other 
hand, is common in both poultry and humans [16,29]. 
The detection of the mcr-1 gene in isolates that belong 
to different sequence types illustrates the potential for 
horizontal transfer of this resistance gene.
Although all chicken meat samples were bought in 
Dutch supermarkets, the labelling of the samples did 
not provide any clue with respect to the country where 
animals were raised. Available data on the origin of the 
chicken meat were limited to the producing country for 
the samples from 2014 (non-Dutch, European), for the 
2009 isolate this information was not available. A non-
European origin of the mcr-1-positive meat samples 
can, therefore, neither be confirmed, nor excluded.
The absence of the mcr-1 gene in human isolates of 
various origins is in accordance with observations in 
previous studies that the presence of the mcr-1 gene 
in clinical isolates is still rare. In China, 1.4% (13/902) 
of clinical E. coli isolates and 0.7% (3/420) of clini-
cal K. pneumoniae isolates were mcr-1-positive, and 
in Denmark, only 0.2% (1/417) of ESBL- and AmpC-
producing E. coli isolates from bloodstream infections 
[2,3]. This absence of the mcr-1 gene in current Dutch 
collections of human Enterobacteriaceae may in part be 
due to the low use of colistin and its analogues, the 
polymyxins, in humans in the Netherlands. In 2014, 
polymyxins constituted less than 0.1% (0.01 defined 
daily dose (DDD)/1,000 inhabitant-days) of all systemic 
antimicrobials used in primary care and ca 0.3% (0.2 
DDD/100 patient-days) of systemic antimicrobials used 
in the hospital setting [30].
Short-read sequence data are not optimal for the 
assembly of plasmid sequences, which are known to 
contain multiple repetitive elements. This may explain 
why the analysis of our sequence data did not reveal a 
link between the mcr-1 gene and the plasmid replicons 
identified.
Although the prevalence of mcr-1-positive isolates in 
meat samples was low, the presence of this colistin 
resistance gene in food represents a potential public 
health threat, as it is located on mobile genetic ele-
ments that have the potential to spread horizontally to 
other bacteria. With the increase in carbapenem resist-
ance, the use of colistin is increasing and, herewith, 
the selective pressure for the spread of mcr-1 gene-
containing plasmids. As colistin has become one of the 
last resort antibiotic options to treat severe infections 
with Gram-negative bacteria, the continued monitor-
ing of colistin resistance and its underlying resistance 
mechanisms is important, not only in humans, but also 
in food production animals and food. The emergence 
of plasmid-mediated colistin resistance underpins the 
recent proposal of veterinary experts to reconsider the 
use of colistin and its analogues in food production 
animals [31].
In conclusion, the plasmid-mediated colistin resistance 
gene mcr-1 was detected in three ESBL-producing E. 
coli isolates that had been cultured from retail chicken 
meat from Dutch supermarkets in 2009 and 2014. Two 
isolates were obtained from the same batch of meat 
samples, which most likely represents contamination 
from a common source. The mcr-1 gene was not pre-
sent in a large collection of human isolates collected 
between 2009 and 2015 in the Netherlands. These find-
ings indicate that mcr-1-based colistin resistance cur-
rently poses no threat to healthcare in the Netherlands, 
but requires continued monitoring of colistin resistance 
and its underlying mechanisms in humans, livestock 
and food.
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